CIK 0001835022 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Coya Therapeutics, Inc.
Sign in to watch- Ticker
- COYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650.739.3939
- Business address
- 12645 MEMORIAL DR., SUITE F1 #305, HOUSTON, TX, 77024
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-09 | Berman Howard Director | Grant or award · Stock Option (right to buy) | +150,602 | 150,602 | ||
| 2025-01-01 | GOLDSTEIN DOV A MD Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2025-01-01 | ROSS WILBUR L JR Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2025-01-01 | Lee Ann Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2025-01-01 | Villalobos Anabella Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2025-01-01 | Weinand Dieter Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2024-11-14 | SNYDER DAVID S Chief Financial Officer | Purchase | +1,800 | $7.19 | $13K | 8,800 |
| 2024-11-13 | Swaminathan Arun Chief Executive Officer | Purchase | +5,000 | $7.36 | $37K | 10,000 |
| 2024-11-11 | Grossman Fred Chief Medical Officer | Purchase | +2,710 | $7.37 | $20K | 2,710 |
| 2024-11-11 | Swaminathan Arun Chief Executive Officer | Purchase | +5,000 | $7.34 | $37K | 5,000 |
| 2024-06-03 | SNYDER DAVID S Chief Financial Officer | Grant or award · Stock Option (right to buy) | +70,596 | 70,596 | ||
| 2024-06-03 | Berman Howard Chief Executive Officer | Grant or award · Stock Option (right to buy) | +163,663 | 163,663 | ||
| 2024-06-03 | Grossman Fred Chief Medical Officer | Grant or award · Stock Option (right to buy) | +70,596 | 70,596 | ||
| 2024-01-31 | SNYDER DAVID S Chief Financial Officer | Grant or award · Stock Option (right to buy) | +81,819 | 81,819 | ||
| 2024-01-31 | Berman Howard Chief Executive Officer | Grant or award · Stock Option (right to buy) | +189,680 | 189,680 | ||
| 2024-01-31 | Grossman Fred Chief Medical Officer | Grant or award · Stock Option (right to buy) | +81,819 | 81,819 | ||
| 2024-01-31 | Grossman Fred Chief Medical Officer | Grant or award · Stock Option (right to buy) | +74,069 | 74,069 | ||
| 2024-01-02 | ROSS WILBUR L JR Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2024-01-01 | Garren Hideki Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2024-01-01 | GOLDSTEIN DOV A MD Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 |
Page 2 of 4 · 65 trades